Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.
Cannara Biotech has raised $4.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Cannara Biotech's investors include CIBC, Bank of Montreal, Keiretsu Forum, Phoenician Capital, Olympic Investments.
Cannara Biotech is headquartered in Saint Laurent, Canada.
Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.
Cannara Biotech is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cannara Biotech — Funding & Investors." VCBacked, February 4, 2026, https://www.vcbacked.co/company/cannara-biotech. Accessed August 17, 2026.
VCBacked. (2026). Cannara Biotech — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/cannara-biotech
{{cite web |title=Cannara Biotech — Funding & Investors |url=https://www.vcbacked.co/company/cannara-biotech |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated